New ACTG Trial Aims to Control HIV Without the use of ART
The AIDS Clinical Trials Group (ACTG) announced Monday that a new clinical trial called A5374 has begun. The new trial aims to treat HIV patients with a combination of three therapies that include a therapeutic T-cell vaccines, two broadly neutralizing …